With patients facing more exposure to the cost of revolutionary new medications, the budget President Barack Obama released Monday reopened a debate on whether government should use its buying power to squeeze the pharmaceutical industry for lower prices. Obama called on Congress to allow the secretary of Health and Human Services to negotiate prices on behalf of Medicare beneficiaries for high-cost drugs and for biologics, which are medications derived from natural substances, ranging from insulin to some of the latest cancer treatments.